タイトル | Structural studies of several clinically important oncology drugs in complex with human serum albumin. |
---|
ジャーナル・号・ページ | Biochim. Biophys. Acta, Vol. 1830, Page 5356-5374, Year 2013 |
---|
掲載日 | 2013年6月17日 (構造データの登録日) |
---|
著者 | Wang, Z.M. / Ho, J.X. / Ruble, J.R. / Rose, J. / Ruker, F. / Ellenburg, M. / Murphy, R. / Click, J. / Soistman, E. / Wilkerson, L. / Carter, D.C. |
---|
リンク | Biochim. Biophys. Acta / PubMed:23838380 |
---|
手法 | X線回折 |
---|
解像度 | 2.01 - 2.8 Å |
---|
構造データ | PDB-4l8u: X-ray study of human serum albumin complexed with 9 amino camptothecin 手法: X-RAY DIFFRACTION / 解像度: 2.01 Å PDB-4l9k: X-ray study of human serum albumin complexed with camptothecin 手法: X-RAY DIFFRACTION / 解像度: 2.4 Å PDB-4l9q: X-ray study of human serum albumin complexed with teniposide 手法: X-RAY DIFFRACTION / 解像度: 2.7 Å PDB-4la0: X-ray study of human serum albumin complexed with bicalutamide 手法: X-RAY DIFFRACTION / 解像度: 2.4 Å PDB-4lb2: X-ray study of human serum albumin complexed with idarubicin 手法: X-RAY DIFFRACTION / 解像度: 2.8 Å PDB-4lb9: X-ray study of human serum albumin complexed with etoposide 手法: X-RAY DIFFRACTION / 解像度: 2.7 Å |
---|
化合物 | ChemComp-EHF: (2S)-2-hydroxy-2-[8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl]butanoic acid / カルボン酸型カンプトテシン / 阻害剤*YM
ChemComp-9TP: (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol / テニポシド / 薬剤, toxin*YM
ChemComp-EVP: (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol / エトポシド / 薬剤, 化学療法薬*YM
|
---|
由来 | - homo sapiens (ヒト)
|
---|
キーワード | TRANSPORT PROTEIN / PLASMA PROTEIN / Oncology Drugs / protein drug complex / Cancer / Oncology Drug Complex |
---|